Evaluation of the vitamin A on the treatment of Brucellosis.

Evaluation of the effect of vitamin A adjuvant therapy on the decrease of relapse of Brucellosis.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180815040807N1

Enrollment

110

Registered

2018-10-28

Start date

2018-07-03

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brucellosis. Brucellosis

Interventions

Intervention 1: Intervention group: Patients in the intervention group, in addition to receiving the usual treatment for brucellosis, will receive vitamin with a dose of 25,000 units daily for 6 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients who have positive serologic tests for Brucella.

Exclusion criteria

Exclusion criteria: All patients with focal complications of Brucellosis include Brucella spondylitis, Brucella endocarditis, and Neurobuccosis. All patients who have any immune deficiency.

Design outcomes

Primary

Measure	Time frame
Relapse. Timepoint: Before the intervention, 1, 3, 6, 12 and 15 months after the intervention. Method of measurement: Patients will be evaluated for the disease recurrence by measuring antibody titres against brucellosis.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNoushin ahmadvand

Arak University of Medical Sciences

n.ahmadvand@arakmu.ac.ir+98 86 3417 3503

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026